SPINDLE CELL RHABDOMYOSARCOMA - A PROGNOSTICALLY FAVORABLE VARIANT OF RHABDOMYOSARCOMA

被引:186
作者
CAVAZZANA, AO
SCHMIDT, D
NINFO, V
HARMS, D
TOLLOT, M
CARLI, M
TREUNER, J
BETTO, R
SALVIATI, G
机构
[1] UNIV PADUA,INST PATHOL,I-35100 PADUA,ITALY
[2] UNIV PADUA,DEPT PEDIAT,I-35100 PADUA,ITALY
[3] UNIV PADUA,RES COUNCIL,MUSCLE BIOL UNIT,I-35100 PADUA,ITALY
[4] UNIV KIEL,INST PATHOL,W-2300 KIEL 1,GERMANY
[5] OLGA HOSP,CTR PEDIAT,DEPT ONCOL HEMATOL,W-7000 STUTTGART 1,GERMANY
关键词
RHABDOMYOSARCOMA; SPINDLE CELL RHABDOMYOSARCOMA; SKELETAL MUSCLE;
D O I
10.1097/00000478-199203000-00002
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Twenty-one cases of embryonal rhabdomyosarcoma, composed mainly of elongated spindle cells arranged in a fasciculated or storiform pattern, were retrieved from the files of the German-Italian Cooperative Soft Tissue Sarcoma Study. The term spindle cell rhabdomyosarcoma is proposed to designate this histotype. Spindle cell rhabdomyosarcoma predilected male patients (18 males, three females) and involved mostly the paratesticular area (12 cases) and the head and neck region (six cases). Histologically, all cases were characterized by a uniform proliferation of elongated spindle cells with eosinophilic and fibrillar cytoplasm mimicking smooth muscle fibers; immunocytochemical studies disclosed high expression of the muscle markers titin, desmin, and myoglobin. Clinical information was available in 17 cases, according to the Intergroup Rhabdomyosarcoma Study (IRS) grouping system, 13 were classified in group I, two in group II, and two in group III. Sixteen patients were well and alive 24 to 100 months after diagnosis; one patient died from disease progression 24 months after diagnosis. Analysis of our results determined that spindle cell rhabdomyosarcoma constitutes a rare variant of the embryonal form, showing a high degree of skeletal muscle differentiation and a low malignant potential; it should therefore be distinguished from classical forms of embryonal rhabdomyosarcoma.
引用
收藏
页码:229 / 235
页数:7
相关论文
共 33 条
  • [1] BALE PM, 1986, PATHOLOGY NEOPLASIA, P196
  • [2] LONG-TERM RESULTS IN CHILDHOOD RHABDOMYOSARCOMA - A RETROSPECTIVE STUDY IN ITALY
    CARLI, M
    DEBERNARDI, B
    CASTELLO, M
    MADON, E
    PAOLUCCI, G
    ZANESCO, L
    PASTORE, G
    [J]. PEDIATRIC HEMATOLOGY AND ONCOLOGY, 1986, 3 (04) : 371 - 378
  • [3] CARLI M, 1990, P ANN M AM SOC CLIN, V9, P297
  • [4] CARLI M, 1984, PEDIATR MED CHIR, V6, P179
  • [5] PROGNOSIS IN CHILDREN WITH RHABDOMYOSARCOMA - A REPORT OF THE INTERGROUP RHABDOMYOSARCOMA STUDIES-1 AND STUDIES-2
    CRIST, WM
    GARNSEY, L
    BELTANGADY, MS
    GEHAN, E
    RUYMANN, F
    WEBBER, B
    HAYS, DM
    WHARAM, M
    MAURER, HM
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1990, 8 (03) : 443 - 452
  • [6] ENZINGER FM, 1969, CANCER, V24, P18, DOI 10.1002/1097-0142(196907)24:1<18::AID-CNCR2820240103>3.0.CO
  • [7] 2-5
  • [8] Enzinger RM., 2011, SOFT TISSUE TUMORS, P1178
  • [9] FLAMANT F, 1984, CANCER, V53, P2417, DOI 10.1002/1097-0142(19840601)53:11<2417::AID-CNCR2820531109>3.0.CO
  • [10] 2-#